Overview

Skeletal Muscle and Adipose Tissue Study

Status:
Active, not recruiting
Trial end date:
2022-04-01
Target enrollment:
0
Participant gender:
All
Summary
The purpose of this research study is to compare the current standard of care for prophylactic Cefazolin administered every 3 hours intravenously with continuous infusion of Cefazolin during pediatric spinal surgery.
Phase:
Phase 4
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
University of Florida
Treatments:
Cefazolin
Dialysis Solutions
Criteria
Inclusion Criteria:

- Diagnosis of idiopathic scoliosis

- Planned posterior spinal fusion surgery (PSFS)

- Age: 12-20 years old

- American Society of Anesthesiology status I or II undergoing posterior spinal fusion
for at least 6 levels

- No known allergy to cefazolin

Exclusion Criteria:

- Known allergy to cefazolin

- Anatomical or other abnormalities that precluded insertion of a microdialysis catheter
into the selected paraspinal muscle

- Known renal or hepatic insufficiency or failure